Both programs are open to MD/DO/MBBS, NMD, DMD/DDS, NP/APRN/CRNA, PA, and PharmD
As in the previously mentioned study there was no difference between GLP-1 receptor agonists and SGLT2 inhibitors in reducing the risk of MACE, but when compared to DPP-4 inhibitors SGLT2 inhibitors significantly reduced cardiovascular and total death
Prescribing GLP-1 agonists for AUD would constitute off-label use , which requires careful consideration of the evidence base, documented informed consent, clear rationale, appropriate monitoring, and adherence to local governance frameworks
(2025, January)
But heres the truth: Pills are often destroyed in the stomach or filtered by the liver
For weight-loss seekers who are Quartz members, there is no insurance-covered path for Ozempic weight-loss use